Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Near-Infrared Light Photobiomodulation Treatment for Retinal Vein Occlusion Macular Oedema

NCT: NCT04847869 · TERMINATED

NCT IDNCT04847869
StatusTERMINATED
Start Date2021-01-01
Completion2024-07-31
SponsorUniversity of Sydney (OTHER)
First posted
Last updated

Brief Summary

This pilot study aims to establish that treatment with near infrared light (NIR) reduces cystic macular oedema in patients with a retinal vein occlusion.

Frequently Asked Questions

What is Near-Infrared Light Photobiomodulation Treatment for Retinal Vein Occlusion Macular Oedema?

Near-Infrared Light Photobiomodulation Treatment for Retinal Vein Occlusion Macular Oedema is a clinical trial registered under NCT04847869. Current status: TERMINATED.

What is the status of NCT04847869?

The current status of NCT04847869 (Near-Infrared Light Photobiomodulation Treatment for Retinal Vein Occlusion Macular Oedema) is: TERMINATED.

When did Near-Infrared Light Photobiomodulation Treatment for Retinal Vein Occlusion Macular Oedema start?

Near-Infrared Light Photobiomodulation Treatment for Retinal Vein Occlusion Macular Oedema started on 2021-01-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑